LIP
RCEL icon

Lighthouse Investment Partners’s Avita Medical RCEL Stock Holding History

Lighthouse Investment Partners’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,026
Closed -$66.2K – 360
2022
Q4 		$66.2K Buy
+10,026
New +$60.1K 0.01% 240

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Lighthouse Investment Partners's RCEL Position: Q1 2023 in Review

Lighthouse Investment Partners sold out of Avita Medical (RCEL) in Q1 2023, closing a stake of 10,026 shares — an estimated $66.2K sold.

Lighthouse Investment Partners first reported a position in RCEL in Q4 2022 and held it in 1 quarter. The position peaked at $66.2K in Q4 2022. 71 funds tracked by Wall St. Rank hold RCEL as of Q1 2023.

  • Lighthouse Investment Partners reported no remaining Avita Medical position as of Q1 2023 after selling out during the quarter.
  • Lighthouse Investment Partners sold 10,026 Avita Medical shares in Q1 2023, an estimated $66.2K.
  • Lighthouse Investment Partners first reported a position in Avita Medical in Q4 2022 and held it in 1 quarter.
  • Lighthouse Investment Partners's Avita Medical position peaked at $66.2K in Q4 2022.
  • 71 funds tracked by Wall St. Rank held Avita Medical as of Q1 2023.

Based on Lighthouse Investment Partners's 13F filing for Q1 2023, filed 15 May 2023.